Improvement in thrombolytic therapy administration in acute stroke with feedback

Canadian Journal of Neurological Sciences

Volumn 39, Issue 6, 2012, Pages 789-792

  Ghrooda, Esseddeeg ^a   Alcock, Susan ^b   Jackson, Alan C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY NURSE PRACTITIONER; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEEDBACK SYSTEM; FIBRINOLYTIC THERAPY; HUMAN; NEUROLOGIST; PRIORITY JOURNAL; RADIOLOGICAL TECHNOLOGIST; RETROSPECTIVE STUDY;

EID: 84867923597     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100015626     Document Type: Article

References (14)

1. Lindsay MP, Gubitz G, Bayley M, Hill MD. Canadian Best Practice Recommendations for Stroke Care (Update 2010). On behalf of the Canadian Stroke Strategy Best Practices and Standards Writing Group. 2010. Ottawa, Ontario, Canada: Canadian Stroke Network. Available from: http://www. canadianstrokestrategy.ca/eng/home.html
2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-7.
3. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317-29.
4. Bluhmki E, Chamorro A, Davalos A, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): Additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12): 1095-102.
5. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009; CD000213.
6. Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123 (19):750-8.
7. Saver JL. Time is brain-quantified. Stroke. 2006;37(1):263-6.
8. Chatterjee P, Cucchiara BL, Lazarciuc N, Shofer FS, Pines JM. Emergency department crowding and time to care in patients with acute stroke. Stroke. 2011;42(4):1074-80.
9. Assanasen S, Edmond M, Bearman G. Impact of 2 different levels of performance feedback on compliance with infection control process measures in 2 intensive care units. Am J Infect Control. 2008;36(6):407-13.
10. Frenzel JC, Kee SS, Ensor JE, Riedel BJ, Ruiz JR. Ongoing provision of individual clinician performance data improves practice behavior. Anesth Analg. 2010;111(2):515-9.
11. Berhe M, Edmond MB, Bearman G. Measurement and feedback of infection control process measures in the intensive care unit: Impact on compliance. Am J Infect Control. 2006;34(8):537-9.
12. Duncan K, Pozehl B. Effects of performance feedback on patient pain outcomes. Clin Nurs Res. 2000;9(4)379-97.
13. Whiteman R, Gould L, Oczkowski W, LeBlanc K, Leonard P. Using a quality improvement process to create measurable improvement in care delivery for acute stroke. Healthcare Quarterly. 2011;14(3):75-9.
14. Canadian Stroke Network. The quality of stroke care in Canada 2011; 2011. Available from: http://www.canadianstroke network.ca.